May 16 |
Q1 2024 Abeona Therapeutics Inc Earnings Call
|
May 15 |
Abeona Therapeutics GAAP EPS of -$1.16 misses by $0.65
|
May 15 |
Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress
|
May 7 |
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
May 3 |
Abeona Therapeutics prices its $75M offering; shares rise
|
May 3 |
Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
|
May 2 |
Buying The Dip In Abeona Therapeutics After The Recent Manufacturing-Related CRL
|
Apr 25 |
ABEO: Receives CRL Based on Need for More CMC Information…
|
Apr 23 |
Abeona Therapeutics Tanks On CRL From The FDA, But All Hope Is Not Lost
|
Apr 23 |
Dow Jumps Over 200 Points; US Services PMI Falls In April
|